Mercator Medical Financials
| MRC Stock | 50.70 1.70 3.47% |
Mercator |
| Foreign Associate | USA |
| Instrument | Poland Stock View All |
| Exchange | Warsaw Stock Exchange |
| ISIN | PLMRCTR00015 |
| Business Address | ul Heleny Modrzejewskiej |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | mercatormedical.eu |
| Phone | 48 512 30 03 97 |
You should never invest in Mercator Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Mercator Stock, because this is throwing your money away. Analyzing the key information contained in Mercator Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Mercator Medical Key Financial Ratios
There are many critical financial ratios that Mercator Medical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Mercator Medical reports annually and quarterly.| Return On Equity | 0.0179 | |||
| Return On Asset | -0.0044 | |||
| Beta | 2.93 | |||
| Z Score | 1.0 |
Mercator Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mercator Medical's current stock value. Our valuation model uses many indicators to compare Mercator Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mercator Medical competition to find correlations between indicators driving Mercator Medical's intrinsic value. More Info.Mercator Medical SA is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mercator Medical's earnings, one of the primary drivers of an investment's value.Mercator Medical Systematic Risk
Mercator Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Mercator Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Mercator Medical correlated with the market. If Beta is less than 0 Mercator Medical generally moves in the opposite direction as compared to the market. If Mercator Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Mercator Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Mercator Medical is generally in the same direction as the market. If Beta > 1 Mercator Medical moves generally in the same direction as, but more than the movement of the benchmark.
Mercator Medical Thematic Clasifications
Mercator Medical SA is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Mercator Medical December 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Mercator Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Mercator Medical SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mercator Medical SA based on widely used predictive technical indicators. In general, we focus on analyzing Mercator Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mercator Medical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 18.2 | |||
| Value At Risk | (4.26) | |||
| Potential Upside | 4.17 |
Additional Tools for Mercator Stock Analysis
When running Mercator Medical's price analysis, check to measure Mercator Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mercator Medical is operating at the current time. Most of Mercator Medical's value examination focuses on studying past and present price action to predict the probability of Mercator Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mercator Medical's price. Additionally, you may evaluate how the addition of Mercator Medical to your portfolios can decrease your overall portfolio volatility.